Description

Ditrisarubicin C is a specialized anthracycline derivative of significant interest in advanced pharmaceutical research and development. Its value lies in its potential as a key intermediate or active pharmaceutical ingredient (API) for novel therapeutic agents, particularly in oncology. This compound is essential for research institutions, pharmaceutical manufacturers, and biotechnology companies engaged in the synthesis and study of next-generation cancer treatments and other specialized medical applications.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of novel anthracycline-based chemotherapeutic agents.
• Oncology Research: Used in preclinical and clinical research to study structure-activity relationships, efficacy, and mechanisms of action of new anti-cancer compounds.
• API Development: Acts as a precursor or the core structure in the development of new Active Pharmaceutical Ingredients (APIs) targeting various cancers.
• Biochemical Research: Employed in studies investigating DNA intercalation, topoisomerase inhibition, and other biological pathways relevant to anthracyclines.
• Reference Standard: Utilized as a high-purity analytical standard for quality control and method development in pharmaceutical laboratories.

Basic Information

Product Name	Ditrisarubicin C
CAS No.	87385-18-0
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	4'-Deoxy-4'-iododoxorubicin; 4'-Iodo-4'-deoxydoxorubicin; Iodoxorubicin; 4'-Iododoxorubicin; (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione 4'-iodo derivative
EINECS	Contact for details

Quality Control

Our Ditrisarubicin C is manufactured and controlled under a strict quality management system. Each batch undergoes comprehensive analytical testing, including identification, purity assay, and impurity profiling via advanced techniques like HPLC, to ensure it meets the high standards required for pharmaceutical research and development. Certificates of Analysis (COA) detailing all test results are provided to guarantee traceability, consistency, and compliance with your specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider conditions under an inert atmosphere.

Specification

Item	Specification
Appearance	Red to orange-red powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Water Content (KF)	≤ 5.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.